AJMC September 11, 2024
Policy changes, such as banning spread pricing and promoting transparency, are necessary to realign the pharmacy benefit manager (PBM) market and ensure that health care resources benefit patients and providers rather than being diverted by middlemen, according to panelists at the Community Oncology Alliance Payer Exchange Summit.
Policy changes, such as banning spread pricing and delinking core issues, are crucial to realigning the pharmacy benefit manager (PBM) market and ensuring that the resources invested in health care go back to patients and care providers, claimed panelists at the Community Oncology Alliance Payer Exchange Summit.1
The panel discussed the potential for direct contracting between employers and pharmaceutical companies as an alternative to the traditional PBM model, but noted the challenges in...
Today's Sponsors
Today's Sponsor